PRTA
Prothena Corporation plc
NASDAQ · IEHealthcareBiotechnology
$8.67+0.12%
Price as of Jul 20, 2026
PRTA valuation
Prothena Corporation plc valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- 11.23x
- P/E 2027E
- —
- P/E 2028E
- 25.16x
- P/S forward
- 7.12x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.45x
- Price / sales
- 7.83x
- Price / cash flow
- -5.58x
Enterprise value
- Enterprise value
- $132.1M
- EV / sales
- 2.28x
- EV / EBITDA
- -1.77x
- EV / EBIT
- -1.05x
- Market cap
- $453.9M
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.